Cartesian Therapeutics Inc. (RNAC) — Net Asset Quality Index
Cartesian Therapeutics Inc. (RNAC) has a Net Asset Quality Index of -51.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $288.39 Million minus total liabilities of $436.51 Million yields net assets of $-148.12 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check RNAC cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Cartesian Therapeutics Inc. Net Asset Quality Index Over Time (2014–2025)
This chart shows how Cartesian Therapeutics Inc.'s Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the index stands at -51.4%, representing net assets of $-148.12 Million against total assets of $288.39 Million USD. See what is Cartesian Therapeutics Inc.'s book value for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Cartesian Therapeutics Inc. (2014–2025)
The table below presents the year-by-year Net Asset Quality Index for Cartesian Therapeutics Inc. from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see RNAC stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -42.6% | $-126.24 Million | $296.41 Million | $422.65 Million | ▼ -41.0 pp |
| 2024 | -1.6% | $-6.80 Million | $435.02 Million | $441.82 Million | ▲ +142.7 pp |
| 2023 | -144.3% | $-440.18 Million | $305.05 Million | $745.23 Million | ▼ -200.9 pp |
| 2022 | 56.6% | $93.83 Million | $165.89 Million | $72.06 Million | ▲ +42.5 pp |
| 2021 | 14.1% | $22.52 Million | $159.88 Million | $137.36 Million | ▲ +25.0 pp |
| 2020 | -10.9% | $-18.01 Million | $165.44 Million | $183.44 Million | ▼ -19.3 pp |
| 2019 | 8.4% | $8.40 Million | $99.57 Million | $91.17 Million | ▲ +20.6 pp |
| 2018 | -12.2% | $-5.42 Million | $44.48 Million | $49.90 Million | ▼ -63.4 pp |
| 2017 | 51.3% | $51.81 Million | $101.10 Million | $49.29 Million | ▼ -10.3 pp |
| 2016 | 61.5% | $54.96 Million | $89.30 Million | $34.34 Million | ▲ +333.6 pp |
| 2015 | -272.0% | $-116.49 Million | $42.82 Million | $159.32 Million | ▲ +122.8 pp |
| 2014 | -394.8% | $-87.75 Million | $22.23 Million | $109.98 Million | — |